CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.93% | 5.96% | 7.03% | 9.02% | 10.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.93% | 5.96% | 7.03% | 9.02% | 10.88% |
| Cost of Revenue | 5.95% | 7.89% | 8.73% | 11.17% | 13.20% |
| Gross Profit | -7.56% | -4.69% | -2.06% | -2.12% | -0.72% |
| SG&A Expenses | 5.19% | 5.99% | 4.56% | 4.59% | 3.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.87% | 7.67% | 8.23% | 10.37% | 11.98% |
| Operating Income | -43.06% | -33.52% | -19.79% | -18.82% | -10.53% |
| Income Before Tax | -44.97% | -42.10% | 132.03% | 72.80% | 91.45% |
| Income Tax Expenses | -44.31% | -42.09% | 109.01% | 57.75% | 85.88% |
| Earnings from Continuing Operations | -45.20% | -42.10% | 141.02% | 78.66% | 93.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 216.67% | 128.57% | 41.67% | -38.10% | -50.00% |
| Net Income | -44.70% | -41.89% | 142.50% | 78.87% | 93.55% |
| EBIT | -43.06% | -33.52% | -19.79% | -18.82% | -10.53% |
| EBITDA | -31.62% | -24.19% | -13.44% | -13.11% | -7.59% |
| EPS Basic | -43.51% | -40.91% | 141.13% | 80.52% | 97.16% |
| Normalized Basic EPS | -40.89% | -34.51% | -21.36% | -20.74% | -10.25% |
| EPS Diluted | -43.35% | -40.69% | 143.19% | 82.40% | 99.39% |
| Normalized Diluted EPS | -40.80% | -34.41% | -21.30% | -20.63% | -10.03% |
| Average Basic Shares Outstanding | -2.08% | -1.94% | -1.93% | -1.97% | -2.08% |
| Average Diluted Shares Outstanding | -2.23% | -2.10% | -1.98% | -2.08% | -2.31% |
| Dividend Per Share | 9.92% | 9.94% | 9.96% | 9.98% | 10.00% |
| Payout Ratio | 0.95% | 0.86% | -0.56% | -0.40% | -0.44% |
